Last $16.23 USD
Change Today +0.54 / 3.44%
Volume 683.1K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - REGULUS THERAPEUTICS INC (RGLS)

Regulus Therapeutics Inc. to Report Q3, 2014 on Nov 05, 2014
CapIQ 11/05/2014 10:00 PM ET
Regulus Therapeutics Inc. to Report Q2, 2014 on Aug 06, 2014
CapIQ 11/05/2014 10:00 PM ET
Regulus Therapeutics Inc. to Report Q1, 2014 on May 08, 2014
CapIQ 11/05/2014 10:00 PM ET

2013 revenues at Regulus Therapeutics Inc. totaled $19.6M USD, while annual losses equaled $0.46 per share.

Quarterly Earnings & Estimates - REGULUS THERAPEUTICS INC (RGLS)

Actuals vs. Estimates for REGULUS THERAPEUTICS INC RGLS

Regulus Therapeutics Inc.'s Quarterly Earnings

Regulus Therapeutics Inc. reported 1st quarter 2014 losses of $0.30 per share on 05/10/2014.

Annual Earnings & Estimates - REGULUS THERAPEUTICS INC (RGLS)

Actuals vs. Estimates for REGULUS THERAPEUTICS INC RGLS

Regulus Therapeutics Inc.'s Annual Earnings

Regulus Therapeutics Inc. reported annual 2013 losses of $0.46 per share on 03/1/2014.

Quarterly Revenues - REGULUS THERAPEUTICS INC (RGLS)

Actuals vs. Estimates for REGULUS THERAPEUTICS INC RGLS

Regulus Therapeutics Inc.'s Quarterly Revenues

Regulus Therapeutics Inc. had 1st quarter 2014 revenues of $1.6M USD. This missed the $4.1M USD consensus estimate of the 4 analysts following the company. This was -49.6% below the prior year's 1st quarter results.

Annual Revenues - REGULUS THERAPEUTICS INC (RGLS)

Actuals vs. Estimates for REGULUS THERAPEUTICS INC RGLS

Regulus Therapeutics Inc.'s Annual Revenues

Regulus Therapeutics Inc. had revenues for the full year 2013 of $19.6M USD. This was 54.1% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $16.23 USD +0.54

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.74 AUD +0.005
Galena Biopharma Inc $2.07 USD +0.21
Prosensa Holding NV $11.44 USD -0.07
Silence Therapeutics PLC 200.00 GBp -5.00
Tekmira Pharmaceuticals Corp C$17.90 CAD -0.35
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 50.5x
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 48.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.